Fibrosis: Clinical Trials

3 trials for Fibrosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 enrolling by invitation. 3 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 23Enrolling by invitation 3
Phase 31Enrolling by invitation 1

Follow Fibrosis: new trials by email Literature Review of Fibrosis trials Research Report on Fibrosis

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Belumosudil for Abrogation of Interstitial Fibrosis and Tubular Atrophy Following Kidney Transplantation
Belumosudil 200 mg QD, Placebo - Rejection Chronic Renal
Phase 2Enrolling by invitationThe Methodist Hospital Research Institute402025-09-112025-11-12
A Multicenter, Randomized, Controlled Trial of Prednisone Combined With Ursodeoxycholic Acid in the Treatment of Primary Biliary Cholangitis With Moderate to Severe Interface Hepatitis Characteristics
Prednisone, UDCA (Ursodeoxycholic acid) - Primary Biliary Cholangitis (PBC)
Phase 2 / Phase 3Enrolling by invitationHan Ying2442024-10-302026-10-29
Fingolimod for the Abrogation of Interstitial Fibrosis and Tubular Atrophy Following Kidney Transplantation
Fingolimod, Placebo - Interstitial Fibrosis, Kidney Transplant; Complications
Phase 2Enrolling by invitationThe Methodist Hospital Research Institute202022-07-282025-03-14

Narrower conditions

Pulmonary Fibrosis (2)  ·  Kidney Failure, Chronic (1)  ·  Liver Cirrhosis, Biliary (1)  ·  Rejection, Psychology (1)

Broader conditions

Pathologic Processes (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Lung Diseases (2)  ·  Lung Diseases, Interstitial (2)  ·  Respiratory Tract Diseases (2)  ·  Behavior (1)  ·  Bile Duct Diseases (1)  ·  Biliary Tract Diseases (1)  ·  Cholestasis (1)  ·  Cholestasis, Intrahepatic (1)  ·  Chronic Disease (1)  ·  Digestive System Diseases (1)  ·  Disease Attributes (1)  ·  Female Urogenital Diseases (1)

Interventions

Fingolimod Hydrochloride (1)  ·  Methylcellulose (1)  ·  Prednisone (1)  ·  Ursodeoxycholic Acid (1)  ·  belumosudil (1)

Sponsors

The Methodist Hospital Research Institute (2)  ·  Han Ying (1)

Countries

United States (2)  ·  China (1)